Patricia Coutinho de Souza

ELTD1, an effective anti-angiogenic target for gliomas: preclinical assessment in mouse GL261 and human G55 xenograft glioma models

M. Lerner, J. Wren, Yunzhou Dong, 2016, Neuro-oncology.

Inhibition of Pediatric Glioblastoma Tumor Growth by the Anti-Cancer Agent OKN-007 in Orthotopic Mouse Xenografts

K. Fung, N. Smith, D. Saunders, 2015, PloS one.

PFKFB3-mediated Pro-glycolytic Shift in Hepatocellular Carcinoma Proliferation

A. Grant, Muneeb Ahmed, Qianhui Dou, 2022, Cellular and molecular gastroenterology and hepatology.

OKN-007 Increases temozolomide (TMZ) Sensitivity and Suppresses TMZ-Resistant Glioblastoma (GBM) Tumor Growth

Chase A. Brown, D. Kong, J. Wren, 2018, Translational oncology.

Visualizing the effects of lactate dehydrogenase (LDH) inhibition and LDH‐A genetic ablation in breast and lung cancer with hyperpolarized pyruvate NMR

A. Grant, G. Varma, V. Sukhatme, 2021, NMR in biomedicine.

OKN-007 decreases free radical levels in a preclinical F98 rat glioma model.

M. Lerner, R. Mason, S. Plafker, 2015, Free radical biology & medicine.